A whole new world
A whole new world - - Business Insights - PharmaTimes
by John Pinching|John Pinching
www.pharmatimes.com/business_insights/2020/a_whole_new_worldA whole new world - - Business Insights - PharmaTimes
by John Pinching|John Pinching
www.pharmatimes.com/business_insights/2020/a_whole_new_worldICON’s Ioannis Katsoulis, Axel Svedbom, Larushka Mellor and Örjan Åkerborg consider trends and strategies to drive uptake of biosimilars in the UK - Magazine Article - PharmaTimes
by John Pinching
www.pharmatimes.com/magazine/2019/october_2019/embracing_biosimilarsInjecting the lightning bolt of digital into the relentless ambition of pharma has created a portal into the future, and not a moment too soon - Magazine Article - PharmaTimes
by John Pinching
www.pharmatimes.com/magazine/2020/december_2020/the_digital_highwayAs the NHS battles to suppress the coronavirus, communities across Britain have been adjusting to a new reality. Meanwhile, pharma has taken on the task of managing, sustaining and boosting its international supply chains. The industry is, so far,
by John Pinching
www.pharmatimes.com/magazine/2020/june_2020/chain_reactionThe rule book when it comes to delivering innovative clinical research is now being rewritten on a monthly basis. There is now a far greater expectation for medical mysteries and biological riddles to be solved in record times. Needless to say, UK
by John Pinching
www.pharmatimes.com/magazine/2020/march_2020/human_raceHow CSOs can look to the future to forge successful relationships with pharma - Magazine Article - PharmaTimes
by John Pinching
www.pharmatimes.com/magazine/2018/december_2018/tomorrow_peopleThe future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, however, we will see the dreamscape of an
by John Pinching
www.pharmatimes.com/magazine/2019/may/a_new_horizonAmid the chaos of Brexit, pioneering clinical research continues defiantly, plotting its way through the complexity of disease and providing patients with the currencies of hope, transformation and reinvention. - Magazine Article - PharmaTimes
by John Pinching
www.pharmatimes.com/magazine/2019/october_2019/trial_blazersThe pharma industry may just have more unsung heroes than any other. - Magazine Article - PharmaTimes
by John Pinching
www.pharmatimes.com/magazine/2019/november_2019/in_the_shadowsAn exciting, futuristic chapter for clinical trials has opened in which participant engagementwill flourish, expansive data will navigate the maze of disease and digital technology will take pharma and patients to previously unexplored dimensions.
by John Pinching
www.pharmatimes.com/magazine/2019/march/resistance_is_futile